Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Cost of Revenue (2020 - 2025)

Privia Health (PRVA) has 6 years of Cost of Revenue data on record, last reported at $6.4 million in Q4 2025.

  • For Q4 2025, Cost of Revenue changed 0.2% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $27.1 million, up 2.61%, while the annual FY2025 figure was $27.1 million, 2.61% up from the prior year.
  • Cost of Revenue reached $6.4 million in Q4 2025 per PRVA's latest filing, down from $7.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $11.2 million in Q2 2021 and bottomed at $3.2 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $6.0 million, with a median of $6.2 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: skyrocketed 403.51% in 2021, then plummeted 56.89% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $3.8 million in 2021, then soared by 36.13% to $5.2 million in 2022, then grew by 20.8% to $6.2 million in 2023, then increased by 3.41% to $6.5 million in 2024, then fell by 0.2% to $6.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $6.4 million in Q4 2025, $7.0 million in Q3 2025, and $6.8 million in Q2 2025.